Figure.

24-hour ambulatory systolic and diastolic blood pressure at week 36 among SURMOUNT-1 participants. Mean 24-hour ambulatory systolic (A) and diastolic (B) blood pressure with least squares mean (LSM; 95% CI) change difference from baseline vs placebo and (C) 24-hour ambulatory systolic blood pressure LSM (SE) and LSM difference (95% CI) between pooled tirzepatide (TZP) doses and placebo among subgroups at week 36. BMI indicates body mass index. n indicates the number of participants in the subgroup with baseline and week 36 value. *P<0.05 vs placebo.